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Abstract
Background: The purpose of this study was to evaluate the feasibility of the use of a quadripolar
left ventricular (LV) lead for cardiac resynchronization therapy and to compare its acute and
mid-term outcomes with those obtained with bipolar leads. Cardiac resynchronization exhibits
a high incidence of problems involving the LV lead when conventional leads are used, and these
problems may be minimized by using multipolar leads.
Methods: We gathered clinical, implant, and follow-up data at 3 and 9 months from 21 con-
secutive patients in whom a quadripolar (Group Q) or bipolar (Group B) lead was used for
a biventricular defibrillator implant.
Results: The leads were successfully implanted in all of the patients. In Group B, more than
one lead was used in 20% (p = 0.048) of cases. There were no clinical differences or differences
in the implant parameters between the two groups except for the radiation dose, which was
greater in group B (p = 0.035). The incidence of problems related to the LV lead during follow-
-up was higher in group B, but the difference was not significant (42.9% vs. 23.8%, p = 0.326).
The use of more than one LV lead was the only variable that was significantly associated with
lead-related problems during follow-up (p = 0.03; OR = 10.8; 95% CI 1.07–108.61).
Conclusions: The quadripolar lead was associated with excellent implantation success rates
and mid-term performance. The multi-programmability capabilities of quadripolar leads
facilitated the achievement of implant goals and helped to reduce problems during the implant
and follow-up. (Cardiol J 2012; 19, 5: 470–478)
Key words: cardiac resynchronization, left ventricular lead, heart failure,
cardiac pacing, coronary sinus
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Introduction
Cardiac resynchronization therapy (CRT) is not
free of problems and complications that may limit
its benefits. Some patients do not respond to the
therapy, and other potential problems include
phrenic stimulation, the absence of an adequate
capture threshold, lead dislocations (especially the
left ventricular [LV]), and in general, a higher rate
of events related to the device compared with pa-
tients who receive cardiac defibrillator (ICD) im-
plants without CRT [1–3]. To overcome many of
these difficulties, new technical advances had been
developed in the last few years but despite these
developments, the leads cannot be properly posi-
tioned in some patients [4], and non-percutaneous
surgical implantation is used whenever possible.
One of the most significant innovations has
been the development of a quadripolar LV lead
(Quartet, model 1458Q, St. Jude Medical, Sylmar,
CA, USA) with a maximum body diameter of 4.7 F,
composed of a distal electrode (D1) and three rings
(M2, M3 and P4) that are capable of applying pa-
cing from the four electrodes. This capability and
the lead’s right ventricle (RV) coil ability to act as
an anode allow up to 10 bipolar pacing configura-
tions (6 purely bipolar and 4 extended bipolar) to
be applied with this quadripolar lead (Fig. 1). The
main goal of this multi-programmability is to de-
crease the need for surgical revisions and prevent
the loss of CRT due to threshold or phrenic stimu-
lation problems that cannot be non-invasively cor-
rected [5–8]. The use of these leads could overcome
the difficulties of successful implantation with con-
ventional leads in some patients [9]. This observa-
tional study involves an analysis of the technical,
acute to mid-term results in a center utilizing the
aforementioned lead and a global comparison of
these results with those obtained in a group of pa-
tients who received conventional bipolar lead im-
plants within the same period of time.
Methods
Patients and left ventricular lead
Consecutive patients with an indication of stan-
dard CRT associated with an ICD, in whom a coro-
nary sinus (CS) lead implant was attempted for the
first time, were included in this study. All of the
patients gave informed consent. LV quadripolar
leads were used in half of the subjects (Group Q),
and conventional bipolar leads from a variety of
manufacturers were used in the other half (Group B).
The lead types were selected prior to implantation
and independently of the patient characteristics. In
both groups, the distal electrode of the ventricular
lead was called P1, and the ring was called M2. For
the quadripolar lead, the other rings were named
M3 and M4, from tip to proximal.
Device implant
At the time of implantation, we gathered de-
mographical and clinical data about the patients,
their type of indication (primary or secondary), QRS
width, baseline rhythm, cardiovascular risk factors,
cardiovascular medications, and New York Heart
Association (NYHA) functional class. We also ob-
tained electronic data related to the implanted de-
vice and the LV leads including the threshold, the
R wave, the final impedance in the programmed
LV lead
RV lead
RV coil
St. Jude — Quadripolar
A B C D
St. Jude — Bipolar
Tip
Can
Medtronic — BipolarBoston — Bipolar
Figure 1. Outline of the different programmable left ventricle (LV) pacing vectors in the studied patients for each lead
type and device manufacturer. For each vector (shown with a blue arrow), the tip and origin of the arrow identify the
anode and cathode, respectively; RV — right ventricle.
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configuration, the final position of the lead, the num-
ber of leads used to achieve the implant goal, the
total radioscopy time and dose of the implant, and
whether the implant was successful in the first ap-
proached vein. In all cases, access for positioning
the LV lead was gained by subclavian venous punc-
ture, and a CS angiography was performed to un-
derstand the venous anatomy and to visualize the
target vein. The final position of the lead and the
final pacing configuration chosen from the program-
mable options available for each LV lead model were
determined in each case by the physician conduct-
ing the implant, with the goals of avoiding purely
anterior positions and finding an equilibrium be-
tween the programmed output current and an ac-
ceptable threshold in the absence of phrenic stim-
ulation. The programmed output targeted a value
at least 1.5 times the obtained capture threshold to
maintain a safety margin between the pacing out-
put and the pacing threshold value +1 V [10]. All
of the patients received prior placement of an ac-
tive fixation defibrillation lead in the RV and, in pa-
tients who did not have chronic atrial fibrillation, an
active fixation lead in the right atrium. The leads
were connected to an appropriate and compatible
generator produced by the same manufacturer as
the leads.
Follow-up and events
The patients were discharged the day after
they received implants in the absence of complica-
tions. Before the patients were discharged, the au-
riculoventricular and interventricular intervals
were optimized by echocardiography and posteroan-
terior and lateral chest X-rays. The patients were
examined at 3 and 9 months after receiving the
implants and when clinical events required an ear-
lier visit or hospitalization for cardiological reasons.
At each visit, we recorded clinical data and data
related to the threshold capture and impedance of
the LV lead pacing, the presence of clinical phrenic
stimulation during the analyzed periods, the radio-
logical positions of the leads, and the need for sur-
gical revision or setting changes.
Definitions
Success of LV lead implant: Lead placed in
a stable position, with a threshold lower than
3 V, and phrenic stimulation limited to a voltage
1.5 times that of the capture threshold’s value.
“LV lead problems”: The first of any of the
following events before discharge, between dis-
charge and the 3-month visit, or between the
3-month visit and the 9-month visit: macro-dislodge-
ment of the LV lead, resulting in the lack of adequate
capture parameters; intermittent or continuous
phrenic stimulation reported by the patient; lack of
LV capture due to a threshold increase at the follow-
-up in the absence of LV lead dislodgement.
Statistical analysis
Data were analyzed with the SPSS program
(version 15.0, SPSS Inc., Chicago, Ill, USA). The
discrete variables were expressed as absolute va-
lues and percentages, and the continuous variables
were expressed as means ± standard deviation.
The categorical variables were compared using
Fisher’s test (for 2 × 2 tables) or the c2 test, while
the continuous variables were compared with Stu-
dent’s t test. P-values less than 0.05 were consid-
ered to be statistically significant.
Results
Baseline characteristics of patients
We included 42 consecutive patients in this
study (mean age 65.6 ± 9.9 years, 69% male), each
of whom received an ICD implant with CRT. Half
of the patients (n = 21) received a quadripolar lead
for LV pacing (Group Q), and the other half (n = 21)
received a bipolar lead (Group B). The general char-
acteristics of the patients are presented in Table 1.
The majority of the patients (39) were receiving
their first device implant. The patients presented
with severely reduced LV ejection fractions (LVEF)
(22.1 ± 5.8%), the NYHA functional class of each
patient was greater than I, and 83% of the included
patients were in sinus rhythm.
We did not observe statistically significant dif-
ferences between the baseline characteristics of the
Group Q and Group B patients, with the exception
that more of the patients in Group B (Table 1) used
diuretics.
Device implantation
Successful percutaneous implantation of the
lead into the CS was achieved in all of the patients
from both groups (100%). In the majority of the
cases (34 patients [81%], 18 in Group Q [85.7%] and
16 in Group B [76.2%], p = 0.697), implantation was
possible on the first attempted branch of the CS. In
Group B, 4 families of bipolar leads were used
(9 models) from three manufacturers. Table 2 pre-
sents the general data about these bipolar leads.
During the implant procedure, a single quadripolar
lead per patient was used in Group Q, while a total
of 26 leads were used in 21 patients in Group B
(Table 2). Two leads were required in 5 patients to
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achieve the implant goal (p = 0.048) (Table 3) due
to a lack of stability (2 patients), an inability to ac-
cess the venous branch (1 patient), or because of
inappropriate acute threshold capture and phrenic
stimulation parameters (2 patients).
No significant differences in the final positions
(tips) of the LV leads, the threshold, the R wave,
the impedance at the final position, or the configu-
ration of the programmed pacing vector of the two
groups were observed (Table 3). In Group B, pa-
tients received significantly higher radiation doses
(p = 0.035) and higher total radioscopy times
(p = 0.054). The configuration of the LV pacing
vector varied widely due to the diversity of options
for each lead and device, especially in Group Q (Fig. 1).
Overall, we were able to program a total of 13 confi-
gurations, but only 3 (P1-M2, P1-RV coil, and
M2-RV coil) were available in both patient groups
(Fig. 1, Table 3). In 7 patients in Group Q (33.3%),
non-programmable final configurations were chosen
using bipolar leads. A final non-programmable LV
pacing configuration was chosen for 1 patient
in Group B using a quadripolar lead. Only 2 acute
complications were observed, both in Group Q
(p = 0.488). One patient with acute pulmonary ede-
ma presented with dislocation of the LV lead
Table 1. General characteristics of the patients studied.
Total (n = 42) Group Q (n = 21) Group B (n = 21) P
Age [years] 65.6 ± 9.9 63.90 ± 9.7 67.33 ± 10.04 0.268
Males 29 (69) 14 (66.7) 15 (71.4) 1.000
Renal insufficiency 7 (16.7) 3 (14.3) 4 (19%) 1.000
Medications:
Beta-blockers 37 (88.1) 19 (90.5) 18 (85.7) 1.000
ACE-I 28 (66.7) 13 (61.9) 15 (71.4) 0.744
ARB 11 (26.2) 7 (33.3) 4 (19.0) 0.484
Diuretics 31 (73.8) 12 (57.1) 19 (90.5) 0.032
Type of Implant: 0.599
First implant 39 (92.9) 20 (95.2) 19 (90.5)
Upgrading from pacemaker 2 (4.8) 1 (4.8) 1 (4.8)
Upgrading from defibrillator 1 (2.4) 0 (0) 1 (4.8)
Cardiomyopathy: 0.758
Ischemic dilated cardiomyopathy 20 (47.6) 9 (42.9) 11 (52.4)
Non-ischemic dilated cardiomyopathy 22 (52.4) 12 (57.1) 10 (47.6)
Indication: 1.000
Primary prevention 33 (78.6) 17 (81) 16 (76.2)
Secondary prevention 9 (21.4) 4 (19) 5 (23.8)
LVEF [%] 22.1 ± 5.8 22.48 ± 6.1 21.7 ± 5.5 0.695
NYHA functional class at time of implant 0.248
I 0 (0) 0 (0) 0 (0)
II 13 (31) 9 (42.9) 4 (19)
III 24 (57.1) 10 (47.6) 14 (66.7)
IV 5 (11.9) 2 (9.5) 3 (14.3)
Type of QRS 0.343
LBBB 28 (66.7) 15 (71.4) 13 (61.9)
Paced 2 (4.8) 0 (0) 2 (9.5)
IVCD 12 (28.6) 6 (28.6) 6 (28.6)
Width of QRS in ms 153 ± 19 151 ± 21 156 ± 17 0.373
Baseline rhythm: 1.000
Sinus rhythm 35 (83.3) 17 (81) 18 (85.7)
Atrial fibrillation 7 (16.7) 4 (19) 3 (14.3)
ACE-I — angiotensin converting enzyme inhibitors; ARB — angiotensin II receptor blockers; LVEF — left ventricular ejection fraction;
NYHA — New York Heart Association; LBBB — left bundle branch block; IVCD — intraventricular conduction disorder; results expressed as n (%)
(discrete variables) and means ± standard deviation (continuous variables)
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Table 2. Left ventricular lead models used in the two groups.
Manufacturer Lead family Lead model Maximum diameter No. of leads
Group Q 21
St. Jude Medical Quartet 1458Q 5.1 F 21
Group B 26
Medtronic Attain Ability 4196 4.6 F 5
Medtronic Attain Ability 4296 5.3 F 1
St. Jude Medical Quickflex 1156T 5.6 F 3
St. Jude Medical Quickflex 1258T 4.3 F 2
Boston Scientific Acuity 4554 5.4 F 2
Boston Scientific Acuity 4555 5.4 F 10
Boston Scientific Easytrack-2 4543 5.7 2
Boston Scientific Easytrack-3 4548 6 1
Group Q — group with quadripolar lead; Group B — group with bipolar lead
Table 3. Comparison of implant parameters of the two groups.
Total (n = 42) Group Q (n = 21) Group B (n = 21) P
Position of the LV lead tip: 0.440
Basal-lateral 5 (11.9) 1 (4.8) 4 (19.0)
Medio-lateral 20 (47.6) 12 (57.1) 8 (38.1)
Apical-lateral 4 (9.5) 3 (14.3) 1 (4.8)
Basal-posterior 1 (2.4) 1 (4.8) 0 (0)
Medio-posterior 4 (9.5) 2 (9.5) 2 (9.5)
Apical-posterior 2 (4.8) 0 (0) 2 (9.5)
Basal-anterolateral 3 (7.1) 1 (4.8) 2 (9.5)
Medio-anterolateral 1 (2.4) 0 (0) 1 (4.8)
Apical-anterolateral 2 (4.8) 1 (4.8) 1 (4.8)
LV threshold [V] 1.08 ± 0.56 1.03 ± 0.56 1.14 ± 0.56 0.541
Pacing impedance [Ohm] 836 ± 281 799 ± 239 874 ± 318 0.391
LV R wave [mV] 14.3 ± 4.8 14.1 ± 4.9 14.6 ± 4.9 0.754
Radioscopy dose [cGy/cm2] 4367 ± 3608 3191 ± 2357 5544 ± 4269 0.035
Duration of radioscopy [min] 32.2 ± 20 26 ± 11 38.3 ± 26 0.054
Programmed LV configuration:
P1-M2 16 (38.1) 5 (23.8) 11 (52.4)
P1-M4 0 (0) 0 (0) –
M4-M2 0 (0) 0 (0) –
M3-M2 3 (7.1) 3 (14.3) –
M2-M4 0 (0) 0 (0) –
M3-M4 0 (0) 0 (0) –
P1-RV coil 11 (26.2) 2 (9.5) 9 (42.8)
M2-RV coil 7 (16.7) 7 (33.3) 0 (0)
M3-RV coil 1 (2.4) 1 (4.8) –
M4-RV coil 3 (7.1) 3 (14.3) –
M2-P1 0 (0) – 0 (0)
P1-Can 1 (2.4) – 1 (4.8)
M2-Can 0 (0) – 0 (0)
LV — left ventricle; RV — right ventricle; Group Q — group with quadripolar lead; Group B — group with bipolar lead; results expressed as n (%)
(for discrete variables) and mean ± standard deviation(continuous variables)
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during tests with the analyzer, which was resolved
with medical treatment and repositioning of the lead
without further incidents. Another patient present-
ed with severe symptomatic hypotension without
evidence of mechanical complications, and the com-
plication was resolved with vasoactive drugs and
without further incidents.
Follow-up data
There were 4 deaths, all of which occurred
between the 3-month and 9-month follow-up visits.
One death was due to refractory heart failure, ano-
ther occurred during major peripheral artery surgery
on a patient in Group Q, and 2 were related to cardio-
genic shock in patients in Group B. The number of
responders was the same in both groups (81%, 17 of
21 patients per group). The electrical parameters of
the LV leads (pacing threshold and impedance) re-
mained stable in both groups from the time of im-
plantation to the 2 subsequent visits (Table 4).
Clinical phrenic stimulation during follow-up
occurred more frequently in Group B (Table 4). Of
the 10 patients exhibiting phrenic stimulation, only
3 were from Group Q (p = 0.27). Phrenic stimula-
tion in these 10 patients occurred after discharge.
In 4 of the patients (all from group B), phrenic stim-
ulation presented in both the time period between
discharge and the 3-month follow-up visit and be-
tween the 3-month and the 9-month follow-up vis-
its, even though it had been corrected in each of these
patients during the previous visit. In 1 patient,
phrenic stimulation was corrected by reducing the
output and in another, by changing the LV pacing
configuration. In 2 of the 3 patients in which output
reduction was the only option, the safety margin of
the threshold +1 V was reprogrammed to prevent
phrenic stimulation (Cases 9 and 11, Table 5), and
in one of them (Case 11, Table 5), none of the LV
capture and phrenic stimulation thresholds in any
of the possible configurations prevented phrenic
stimulation without losing capture by the 9-month
visit. This patient was programmed without pacing
using the LV lead and underwent surgical revision
and lead repositioning.
The frequencies of loss of capture without and
with macro-dislodgement of the LV lead in the two
groups were not significantly different (Table 4).
We observed a higher frequency of “LV lead
problems” in Group B, but the difference was not
statistically significant (p = 0.326). “LV lead prob-
lems” occurred in one third of the patients (14 pa-
tients [33.3%], 9 from Group B and 5 from Group Q),
and presented most frequently between discharge
and the 3-month follow-up visit. The most frequent
cause was phrenic stimulation (in 9 patients), fol-
lowed by macro-dislodgement of the LV lead (in
Table 4. Comparison of variables related to left ventricular pacing during follow-up in the two groups.
Total (n = 42) Group Q (n = 21) Group B (n = 21) P
LV threshold at 3 months [V] 1 ± 0.5 1.04 ± 0.6 0.97 ± 0.3 0.647
LV impedance at 3 months [Ohm] 754 ± 213 796 ± 220 712 ± 202 0.204
LV threshold at 9 months [V] 0.99 ± 0.3 1.04 ± 0.3 0.94 ± 0.3 0.276
LV impedance at 9 months [Ohm] 722 ± 218 785 ± 218 662 ± 206 0.080
Phrenic stimulation 10 (23.8) 3 (14.3) 7 (33.3) 0.277
Phrenic stimulation before 3 months 6 (14.3) 1 (4.8) 5 (23.8) 0.184
Phrenic stimulation between 3 and 9 months 8 (20.5) 2 (10.5) 6 (30) 0.235
Leads macro-dislodgement 3 (7.1) 1 (4.8) 2 (9.5) 1.000
Loss of capture 2 (4.8) 2 (9.5) 0 (0) 0.488
“LV lead problems” 14 (33) 5 (23.8%) 9 (42.9) 0.326
Causes of “LV lead problems”: N = 14 0.115
Phrenic stimulation 9 (64.3%) 2 (40%) 7 (77.8)
Macro-dislodgement 3 (21.4) 1 (20) 2 (22.2)
Loss of capture 2 (14.3) 2 (40) 0 (0)
Time of  “LV lead problems”: 0.780
Before discharge 2 (14.3) 1 (20) 1 (11.1)
Between discharge and 3 months 10 (71.4) 3 (60) 7 (77.8)
Between 3 and 9 months 2 (14.3) 1 (20) 1 (11.1)
LV — left ventricle; Group Q — group with quadripolar lead; Group B — group with bipolar lead; results expressed as n (%) (for discrete variables)
and mean ± standard deviation (continuous variables)
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3 patients), but there were no statistically signifi-
cant differences between Groups Q and B with re-
spect to the cause or the time of event occurrence
(Table 4). The only variable significantly associat-
ed with the occurrence of “LV lead problem” events
was the use of more than one LV lead during im-
plantation to achieve the target goal (p = 0.03;
OR = 10.8; 95% CI 1.07–108.61). The use of a bipo-
lar LV lead vs. a quadripolar lead, despite the pres-
ence of more events in Group B (9 vs. 5), did not
produce a statistically significant difference. The
data from patients presenting with “LV lead prob-
lem” events are summarized in Table 5.
Regarding post-implant complications not re-
lated to the LV lead, there were 3 cases of pocket
hematoma that required surgical drainage prior to
discharge (2 in Group B and 1 in Group Q), 1 case
of infection in Group Q that was detected during the
9-month follow-up visit and required complete ex-
traction of the system, and a subacute perforation
of the RV by the defibrillation lead in Group Q,
which required surgical revision prior to discharge.
Discussion
Main findings
The main findings of this study include:
(a) CRT using a quadripolar Quartet 1458Q lead for
LV pacing was associated with an excellent implant
success rate, equal to that observed using conven-
tional leads; (b) in this series, the frequency of prob-
lems related to this type of lead was less than that
observed with bipolar leads, although the difference
was not statistically significant; (c) the use of a sin-
gle quadripolar lead was sufficient to achieve the
acute objectives of the implant, while more than one
lead was frequently required when conventional
leads were used.
Previous studies
Outcomes using this quadripolar lead have only
been reported in a few previous studies, two from
the same group (initially with 28 patients [7] and
later with 40 [8]), and another from multiple cen-
ters, including one where 71 patients were analyzed
prospectively [8]. A fourth study represents the
only other comparison of a group of 23 patients with
bipolar leads to a group of 22 patients with quadri-
polar leads but included a follow-up period of only
3 months [5]. All of these prior studies reported
a highly elevated implant success rate for the quad-
ripolar leads, which varied between 95% [8] and
100% [5] of cases. The success rate of quadripolar
lead implantation in the first selected vein in this
work was greater than that reported in a previous
study (85.7% vs. 78% [8]), which could be related
to the larger number of patients with history of
a previous device in this study (32% vs. 4.8%); some
of these previous implantations included a failed
conventional lead implant attempt.
Programming flexibility
The measured stability of the electrical param-
eters after quadripolar lead implants presented in
this study agrees with the observations of previous
studies, and our study includes a longer follow-up
time. This stability and the programming flexibili-
ty of quadripolar leads help to minimize capture and
phrenic stimulation problems during follow-up
(present in over 20% of patients with bipolar leads
[3]) because it is possible to select configurations
that include safety margins between capture and
phrenic stimulation. The majority of the problems
observed during the follow-up periods of previous
studies were corrected without invasive interven-
tions [5, 6, 8], as occurred in our patients. The multi-
programmability of the quadripolar lead facilitates
the observed increased ease of lead placement,
which is indirectly measured by the lower radiation
doses and times (data from our series) and the du-
ration of lead implantation [5]. The use of a quadri-
polar lead was able to achieve the implant goals in
certain patients in whom conventional leads were
insufficient [9].
The quadripolar lead allows us to position the
tip more apically, which facilitates its stability and
permits pacing from more proximal regions, mini-
mizing phrenic stimulation and possibly improving
the clinical results by avoiding pacing in more api-
cal positions [3, 11].
Lead-related problems
In the study by Forleo et al. [5], the frequency
of LV lead malfunction, defined as the need for re-
programming or surgical revision, was significant-
ly higher in the group of patients with bipolar leads.
In our series, the same tendency was clearly ob-
served, but the difference was not statistically sig-
nificant. This difference could be partially explained
by the longer follow-up period used in our study,
in which phrenic stimulation events were observed
in 2 additional patients from Group Q during the
9-month follow-up, while the frequency of this event
at 3 months was the same as that reported in the
previous study [5].
The use of a single lead to achieve the prede-
termined implantation goals was associated with
a lower frequency of problems related to the LV lead
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during follow-up. In the study by Forleo et al. [5]
a single lead was also used in all of the patients from
the quadripolar lead group, but more than 1 lead
was used in 3 patients from the bipolar group. The
use of more than 1 lead to some extent indicated
a suboptimal result in many patients or greater dif-
ficulties in achieving the implantation goals, which
manifested in a higher incidence of problems dur-
ing follow-up. In addition, using a single lead to
obtain an adequate result presents obvious finan-
cial advantages.
Limitations of the study
This study presents certain limitations that
must be considered to adequately analyze the pre-
sented results. While the study is not randomized,
the choice of lead was not influenced by the patients’
characteristics. The study includes a relatively low
number of patients, which may explain the lack of
statistical significance when comparing relevant
variables that exhibited clear group-dependent
trends, such as the “LV lead problems” variable. In
this study, the radioscopy time and radiation dose
data refer to the entire procedure, not only to the
LV lead implant. However, it is acceptable to be-
lieve that the data are homogenous because in nor-
mal practice, the great majority of the radioscopy
time in most cases of these procedures is related
to the lead implantation. The patient follow-up was
short, and no data were collected regarding the in-
cidence of LV lead problems beyond the analyzed
period or about the occurrence of other lead per-
formance problems, especially regarding the quad-
ripolar leads, about which we have limited informa-
tion. However, to the best of our knowledge, this
study has the longest follow-up time reported in the
literature.
Conclusions
The Quartet 1458Q quadripolar leads for LV
pacing are associated with an excellent implanta-
tion success rate and mid-term performance. The
multi-programmability features of this quadripolar
lead model and its associated generator facilitate im-
plantation and help to minimize follow-up problems
related to LV pacing.
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